{
    "clinical_study": {
        "@rank": "137962", 
        "acronym": "RESPPEDHEM", 
        "arm_group": {
            "arm_group_label": "allogeneic hematopoietic stem cell", 
            "arm_group_type": "No Intervention", 
            "description": "The eligible population for this study will consist of all children under 18 years who received allogeneic hematopoietic stem cell and evaluate of late pulmonary complications occurring in children treated with allogeneic hematopoietic stem cells."
        }, 
        "brief_summary": {
            "textblock": "Hematopoietic stem cell transplantation (HSCT) is used to treat an expanding array of\n      malignant and non-malignant disorders. This is a prospective multicenter study, in pediatric\n      allo-BMT recipients to analyze the spectrum of noninfectious pulmonary complications (PC),\n      to evaluate the prevalence and course of PFT abnormalities before and after transplant, and\n      to detect risk factor for PC."
        }, 
        "brief_title": "Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.", 
        "completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Bone Marrow Transplant Infection", 
            "Bronchiolitis Obliterans", 
            "Chronic Respiratory Insufficiency", 
            "Organizing Pneumonia", 
            "Pulmonary Cytolytic Thrombi"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bronchiolitis", 
                "Bronchiolitis Obliterans", 
                "Pneumonia", 
                "Respiratory Insufficiency", 
                "Thrombosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "It's a multicenter prospective study in France. All children under 18 years are included,\n      just before the HSCT. The functional test before the HSCT at 6, 12, 18, 24, 30 and 36 months\n      will be collected and a cardiopulmonary exercise test is done one and three years after the\n      HSCT. Thoracic tomodensitometry is done before the HCT and after at 6, 12, 24 and 36 months.\n\n      All data will be collected upon the HSCT, the infections before and after the HSCT, the\n      respiratory symptoms, and the treatment. Bronchia alveolar lavage and serum will be\n      collected and frozen during the study.\n\n      The inclusion will be done during two years and children will be following during three\n      years.\n\n      The purpose is to evaluate the prevalence, the course of PFT abnormalities before and after\n      transplant, and to detect risk factor for PC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: from birth to 18 years\n\n          -  Patient to be treated by allogeneic hematopoietic stem cell  - Parents who have given\n             their signed consent for the study\n\n          -  Affiliation to a social security scheme\n\n        Exclusion Criteria:\n\n          -  non exclusion criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032381", 
            "org_study_id": "P120137", 
            "secondary_id": "2013-A00966-39"
        }, 
        "intervention": {
            "arm_group_label": "allogeneic hematopoietic stem cell", 
            "intervention_name": "late pulmonary complications occurring in children treated with allogeneic hematopoietic stem cells.", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "non infectious pulmonary complications after hematopoietic cell transplant", 
            "functional respiratory test and exercise test", 
            "thoracic tomodensitometry"
        ], 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "contact": {
                "email": "veronique.houdouin@rdb.aphp.fr", 
                "last_name": "houdouin v\u00e9ronique, MD PHD", 
                "phone": "0140033678"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75019"
                }, 
                "name": "Houdouin v\u00e9ronique"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Prospective Study of Late Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.", 
        "overall_contact": {
            "email": "veronique.houdouin@rdb.aphp.fr", 
            "last_name": "Houdouin veronique, MD PHD", 
            "phone": "0140033678"
        }, 
        "overall_official": {
            "affiliation": "APHP", 
            "last_name": "Houdouin V\u00e9ronique, MD PHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Presence of belated non-infectious pulmonary complications", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032381"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Presence of risk factors for belated non-infectious pulmonary complications", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }, 
            {
                "measure": "Survival three years", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }, 
            {
                "measure": "Severity of respiratory disease", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}